- Adjusted EBITDA Increased 8.4% to $300
Million or 15.2% of Net Sales
- 2014 Adjusted EPS of $0.52 Increased
24%; Reported EPS of $0.28
- Company Raises 2014 Outlook for
Adjusted EBITDA, Adjusted EPS and Free Cash Flow
Sealed Air Corporation (NYSE:SEE) today announced financial
results for the third quarter 2014. Commenting on these results,
Jerome A. Peribere, President and Chief Executive Officer, said,
“Our financial and operational performance in the third quarter
exceeded our expectations across all key metrics. Net sales
increased 3.6% on a constant dollar basis, Adjusted EBITDA margin
surpassed 15%, and Adjusted EPS increased 24%. Adjusted gross
profit margin increased 120 basis points as a result of our
continued disciplines and value-added selling approach across all
regions and divisions. Despite macro-economic uncertainties,
currency headwinds and volume declines in the North American
protein market, we are increasing our 2014 outlook for Adjusted
EBITDA and Adjusted EPS and expect to generate approximately $540
million in free cash flow.”
Unless otherwise stated, all results compare third quarter 2014
results to third quarter 2013 results and are presented on a
continuing operations basis. The Rigid Medical Packaging business,
which the Company sold in December 2013, has been presented as
discontinued operations. Reported information is defined as U.S.
GAAP. Year-over-year net sales discussions present both reported
and constant dollar performance. Constant dollar sales performance
excludes the impact of currency translation. Additionally, non-U.S.
GAAP adjusted financial measures, such as Adjusted Earnings Before
Interest Expense, Taxes, Depreciation and Amortization (“Adjusted
EBITDA”), Adjusted Net Earnings, Adjusted Diluted Earnings Per
Share (“Adjusted EPS”) and Tax Rate, exclude the impact of special
items, such as restructuring charges, cash-settled stock
appreciation rights (“SARs”) granted as part of the Diversey
acquisition and certain other one-time items.
Business and Financial
Highlights
- Net sales in the Food Care division of
$983 million increased 3.4% compared to last year and 3.9% on a
constant dollar basis. The increase in net sales was due to
favorable price/mix of 4.0% on volumes that were essentially
unchanged compared to last year. Food Care delivered sales growth
in all regions on an as reported basis and in constant dollars.
Adjusted EBITDA increased 11.1% to $178 million, or 18.1% of net
sales. This increase was due to favorable mix and price/cost spread
as well as cost synergies, partially offset by non-material
inflation.
- The Diversey Care division reported net
sales of $551 million, a 3.5% increase compared to last year. On a
constant dollar basis, net sales increased 3.9% with a volume
increase of 3.7% and favorable price/mix of 0.2%. Latin America
increased 15% on a constant currency basis and 4% on an as reported
basis. AMAT increased 12% on a constant currency basis and 10% on a
reported currency basis. Adjusted EBITDA increased 15.2% to $70
million, or 12.7% of net sales. This increase was primarily due to
higher volume, cost synergies and favorable mix and price/cost
spread, partially offset by non-material inflation.
- The Product Care division reported net
sales of $421 million, a 4.4% increase compared to last year. On a
constant dollar basis, net sales increased by 3.9% primarily due to
a favorable price/mix of 4.5%, partially offset by a 0.6% decline
in volume. North America delivered a 6% increase in net sales on an
as reported basis and in constant dollars. Product Care’s Adjusted
EBITDA increased 7.2% to $74 million, or 17.7% of net sales. This
increase was largely attributable to favorable mix and price/cost
spread as well as cost synergies.
Third Quarter 2014
Summary
Third quarter 2014 net sales of $2.0 billion increased 3.4% on a
reported basis and 3.6% on a constant dollar basis. Favorable
product price/mix was 3.1% and volume increased 0.5%. The Company
delivered constant dollar sales growth in all regions with 8.0%
growth in Latin America, 7.3% in AMAT1, 4.7% in JANZ2, 3.2% in
North America, and 1.0% in Europe. Additionally, third quarter 2014
reported net sales from Developing Regions3 increased 3.2% on a
reported basis and 7.5% in constant dollars, accounting for 26.3%
of total net sales.
Adjusted EBITDA for the third quarter 2014 increased 8.4% to
$300 million, or 15.2% of net sales. This compares to third quarter
2013 of $277 million, or 14.5% of net sales. The 70 basis point
improvement in Adjusted EBITDA margin in the third quarter 2014 was
primarily attributable to favorable mix and price/cost spread and
cost synergies, partially offset by non-material inflation.
Reported third quarter 2014 net earnings were $59 million, or
$0.28 per share, which included special items largely comprised of
costs associated with the previously disclosed restructuring
programs, loss on refinancing activities and development grant
matter. This compares to reported net earnings of $35 million in
the same period a year ago, or $0.17 per share. Adjusted Net
Earnings were $111 million or $0.52 per share in third quarter
2014. This compares to Adjusted Net Earnings of $90 million, or
$0.42 per share in third quarter 2013. Diluted shares outstanding
in the quarter were 213.9 million and 213.7 in the same period a
year ago. The Tax Rate in third quarter 2014 was 27.8% as compared
with 22.1% in third quarter 2013. This year-over-year increase was
primarily due to greater earnings in the U.S. and in other
jurisdictions with higher tax rates, as well as the lapse of
certain U.S. tax laws, including certain foreign rules and the
research and development credit.
As of October 24, 2014, the Company repurchased approximately
752,000 shares under a 10b5-1 share trading plan pursuant to the
Company’s previously announced share repurchase program. These
shares were purchased for approximately $25 million, at an average
price of $33.47. Additionally, as previously disclosed, the Company
repurchased approximately 3.9 million shares from the WRG Asbestos
PI Trust during the second quarter of this year.
Cash Flow and Net Debt
Cash flow used in operating activities for the nine months ended
September 30, 2014 was $482 million, which includes the $930
million payment in February 2014 pursuant to the W. R. Grace &
Co. Settlement agreement (“Settlement agreement”). Excluding the
Settlement agreement payment, cash flow provided by operating
activities was $448 million, which is net of $76 million of
restructuring and $18 million of SARs payments. This compares with
cash provided by operating activities of $234 million, excluding
Settlement agreement accrued interest in the nine months ended
September 30, 2013, which is net of $72 million of restructuring
and $43 million of SARs payments. Capital expenditures were $94
million for the nine months ended September 30, 2014 compared to
$80 million for the nine months ended September 30, 2013.
Free Cash Flow, defined as net cash used in operating activities
less capital expenditures, was a use of $576 million in the nine
months ended September 30, 2014. Excluding the Settlement agreement
payment, Free Cash Flow was a source of $354 million, compared with
a source of $154 million during the same period a year ago.
Compared to December 31, 2013, the Company’s net debt decreased
$137 million to $4.2 billion as of September 30, 2014. This
decrease was primarily a result of Free Cash Flow excluding the
Settlement agreement payment partially offset by amounts paid for
dividends and share repurchases.
1 AMAT is comprised of Asia, Middle East, Africa and Turkey.
2 JANZ is comprised of Japan, Australia and New Zealand.
3 Developing Regions are Africa, Asia (excluding Japan and South
Korea), Central and Eastern Europe, and Latin America.
Outlook for Full Year
2014
The Company estimates net sales to be approximately $7.7 billion
for the full year 2014, which assumes an unfavorable impact of
approximately 2% from foreign currency translation. The Company
previously estimated the impact of unfavorable foreign currency
translation of approximately 1%.
Despite unfavorable currency translation, the Company is
increasing its 2014 full year outlook for Adjusted EBITDA, Adjusted
EPS and Free Cash Flow. Adjusted EBITDA is anticipated to be
approximately $1.110 billion, an increase from the previously
provided forecast of $1.085 billion to $1.095 billion. Adjusted EPS
is expected to be in the range of $1.70 to $1.75 as compared to the
previously provided guidance of $1.65 to $1.70.
Free Cash Flow is estimated to be approximately $540 million as
compared to the previously provided outlook of $485 million. The
Company is revising its 2014 estimates for cash restructuring
charges to be approximately $100 million and maintaining its
forecast for capital expenditures of approximately $150 million.
The Company’s Free Cash Flow target excludes the Settlement
agreement payment referenced above.
Conference Call Information
Date: October 29, 2014 Time: 8:30am (ET)
Webcast: www.sealedair.com in the Investor Relations section
Conference Dial In: (888) 713-4205 (domestic) (617) 213-4862
(international) Participant Code: 57038879 Conference
Call Replay Information Dates: Wednesday,
October 29, 2014 starting at 12:30pm (ET) through Wednesday,
December 3, 2014 at 11:59pm (ET) Webcast: www.sealedair.com in the
Investor Relations section Conference Dial In: (888) 286-8010
(domestic) (617) 801-6888 (international) Participant Code:
80621522
Business
Sealed Air Corporation creates a world that feels, tastes and
works better. In 2013, the Company generated revenue of
approximately $7.7 billion by helping our customers achieve their
sustainability goals in the face of today’s biggest social and
environmental challenges. Our portfolio of widely recognized
brands, including Cryovac® brand food packaging solutions, Bubble
Wrap® brand cushioning and Diversey® cleaning and hygiene
solutions, ensures a safer and less wasteful food supply chain,
protects valuable goods shipped around the world, and improves
health through clean environments. Sealed Air has approximately
25,000 employees who serve customers in 175 countries. To learn
more, visit www.sealedair.com.
Website Information
We routinely post important information for investors on our
website, www.sealedair.com, in the "Investor Relations" section. We
use this website as a means of disclosing material, non-public
information and for complying with our disclosure obligations under
SEC Regulation FD. Accordingly, investors should monitor the
Investor Relations section of our website, in addition to following
our press releases, SEC filings, public conference calls,
presentations and webcasts. The information contained on, or that
may be accessed through, our website is not incorporated by
reference into, and is not a part of, this document.
Non-U.S. GAAP
Information
In this press release and supplement, we have included several
non-U.S. GAAP financial measures, including Adjusted Net Earnings
and EPS, net sales on a "constant dollar" basis, Adjusted Gross
Profit, Adjusted Operating Profit, Free Cash Flow, EBITDA, Adjusted
EBITDA and Tax Rate. We present results and guidance, adjusted to
exclude the effects of certain specified items (“special items”)
and their related tax impact that would otherwise be included under
U.S. GAAP, to aid in comparisons with other periods or prior
guidance. We may use Adjusted EPS, net sales on a constant dollar
basis, Adjusted Net Earnings, Adjusted Gross Profit, Adjusted
Operating Profit, measures of free cash flow, net debt, and
Adjusted EBITDA measures to determine performance-based
compensation. Our management uses financial measures excluding the
effects of foreign currency translation in evaluating operating
performance. Management believes that this information may be
useful to investors. For a reconciliation of these non-U.S. GAAP
measures to U.S. GAAP and other important information on our use of
non-U.S. GAAP financial measures, see the attached supplementary
information entitled “Condensed Consolidated Statements of Cash
Flows” (under the section entitled “Non-U.S. GAAP Free Cash Flow”),
“Reconciliation of U.S. GAAP Condensed Consolidated Statements of
Operations to Non-U.S. GAAP Adjusted Condensed Consolidated
Statements of Operations and Non-U.S. GAAP Adjusted EBITDA,”
“Segment Information,” and “Components of Change in Net Sales by
Segment.”
Forward-Looking
Statements
This press release contains “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements can be identified by such words as
“anticipates,” “believes,” “plan,” “assumes,” “could,” “estimates,”
“expects,” “intends,” “may,” “plans to,” “will” and similar
expressions. These statements reflect our beliefs and expectations
as to future events and trends affecting our business, our
consolidated financial position and our results of operations.
Examples of these forward-looking statements include expectations
regarding our anticipated effective income tax rate, the potential
cash tax benefits associated with the W. R. Grace & Co.
Settlement agreement (as defined in the Company’s Annual Report on
Form 10-K), potential volume, revenue and operating growth for
future periods, expectations and assumptions associated with our
restructuring programs, availability and pricing of raw materials,
success of our growth initiatives, economic conditions, and the
success of pricing actions. A variety of factors may cause actual
results to differ materially from these expectations, including
domestic and international economic and political conditions,
changes in our raw material and energy costs, credit ratings, the
success of restructuring plans, currency translation and
devaluation effects, the competitive environment, the effects of
animal and food-related health issues, environmental matters, and
regulatory actions and legal matters. For more extensive
information, see “Risk Factors” and “Cautionary Notice Regarding
Forward-Looking Statements,” which appear in our most recent Annual
Report on Form 10-K, as filed with the Securities and Exchange
Commission, and as revised and updated by our Quarterly Reports on
Form 10-Q and Current Reports on Form 8-K. While we may elect to
update these forward-looking statements at some point in the
future, we specifically disclaim any obligation to do so, whether
as a result of new information, future events, or otherwise.
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS(1)
(Unaudited)
(In millions, except per share
data)
Three Months Ended Nine Months Ended
September 30, September 30, 2014
2013 2014 2013 Revised(2)
Revised(2)
Net sales $ 1,975.5 $
1,912.0 $ 5,776.8 $
5,678.3 Cost of sales 1,281.9 1,262.1
3,762.3 3,757.1
Gross profit 693.6
649.9 2,014.5 1,921.2 As a % of total net
sales 35.1 % 34.0 % 34.9 % 33.8 % Selling, general and
administrative expenses(3) 467.4 426.0 1,374.5 1,310.6 As a % of
total net sales 23.7 % 22.3 % 23.8 % 23.1 % Amortization expense of
intangible assets acquired 30.4 29.1 92.8 92.4 Stock appreciation
rights expense(4) 1.0 8.7 3.2 26.8 Integration related costs 1.4
0.3 3.3 0.7 Restructuring and other charges 11.4 49.5
31.6 61.2
Operating profit 182.0
136.3 509.1 429.5 Interest expense (69.7 )
(88.9 ) (222.1 ) (269.4 ) Impairments of equity method investment
0.2 (2.1 ) (5.7 ) (2.1 ) Foreign currency exchange (losses) gains
related to Venezuelan
subsidiaries(5)
(4.1 ) 0.7 (18.9 ) (12.9 ) Gain from Claims Settlement(6) — — 21.1
— Loss on debt redemption and refinancing activities(7) (17.7 ) —
(18.5 ) (32.4 ) Other income (expense), net 4.3 0.3
5.8 (2.7 )
Earnings from continuing operations
before income tax
provision
95.0 46.3 270.8 110.0 Income tax
provision 35.7 11.2 79.5 19.9 Effective
income tax rate 37.6 % 24.2 % 29.4 % 18.1 %
Net earnings from
continuing operations 59.3 35.1
191.3 90.1 Net earnings from
discontinued operations(2) —
2.5 —
6.5 Net earnings available to common
stockholders $ 59.3 $ 37.6 $
191.3 $ 96.6 Net earnings per common
share(8): Basic : Continuing operations $
0.28 $ 0.18 $ 0.91 $ 0.46 Discontinued operations —
0.01 — 0.03
Net earnings per common share -
basic $ 0.28 $ 0.19 $
0.91 $ 0.49 Diluted: Continuing
operations $ 0.28 0.17 $ 0.88 0.42 Discontinued operations —
0.01 — 0.03
Net earnings per common share -
diluted $ 0.28 $ 0.18 $
0.88 $ 0.45 Dividends per common share
$ 0.13 $ 0.13 $ 0.39
$ 0.39 Weighted average number of common shares
outstanding: Basic 210.4
194.9 210.2 194.5 Diluted
213.9 213.7 215.7
213.4
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the
Securities and Exchange Commission.
(2) In December 2013, we completed the sale of our rigid medical
packaging business for net cash proceeds of $122 million. The
financial results of the rigid medical packaging business is
reported as discontinued operations, net of tax, and accordingly
all previously reported financial information has been revised.
(3) As previously disclosed in our 2013 Annual Report on Form
10-K, on May 25, 2010, one of our Italian subsidiaries received a
demand from the Italian Ministry of Economic Development (the
“Ministry”) for the total repayment of grant monies paid to two of
our former subsidiaries (a former Product Care business) in the
amount of €5 million. With accrued interest the total value of the
demand currently stands at €10 million ($14 million equivalent at
September 30, 2014). Our Italian subsidiary submitted a total
denial of liability in regard to this matter on June 30, 2010. A
hearing on the merits was held on July 3, 2014; in mid-September,
our subsidiary was advised that the demand for repayment of €10
million was upheld. Accordingly, in the three months ended
September 30, 2014, we have recorded a current liability and
corresponding charge of $14 million ($0.07 per share) related to
this matter. The liability is included in other current liabilities
on the condensed consolidated balance sheets and the charge is
included in selling, general and administrative expenses on the
condensed consolidated statements of operations. The charge is
treated as a special item and included in Corporate in the Other
category. We have filed an application to suspend enforcement of
the judgment pending appeal.
(4) At September 30, 2014, the remaining amount of unvested
cash-settled stock appreciation rights (“SARs”) will fully vest by
March 31, 2015. However, we will continue to incur expense related
to these SARs until the last expiration date of these awards (March
2021). The amount of related future expense will fluctuate based on
exercise and forfeiture activity and changes in the assumptions
used in the valuation model, including the price of Sealed Air
common stock.
(5) Based on changes to the Venezuelan currency exchange rate
mechanisms, we changed the exchange rate we used to remeasure our
Venezuelan subsidiary’s financial statements into U.S. dollars. As
a result of the change in our excess cash position in our
Venezuelan subsidiaries being remeasured, we recorded a
remeasurement loss of $4 million in the three months ended
September 30, 2014 and $19 million in the nine months ended
September 30, 2014. In February 2013, the Venezuelan government
announced a devaluation of the Bolivar from an official exchange
rate of 4.3 to 6.3 bolivars per U.S. dollar. Due to this
devaluation, as of September 30, 2013, we remeasured our bolivar
denominated monetary assets and liabilities, which resulted in a
pretax gain of $1 million in the three months ended September 30,
2013 and a $13 million pretax loss in the nine months ended
September 30, 2013.
(6) As previously disclosed in our Quarterly Report on
Form 10-Q for the three months ended March 31, 2014, on
February 3, 2014 we funded the cash consideration
($930 million) and issued the shares reserved under the
Settlement agreement as defined therein. As a result, we recognized
a gain on Claims Settlement of $21 million, which primarily
consisted of the release of certain tax and other liabilities.
(7) On July 25, 2014, we refinanced our amended and
restated credit with Bank of America, N.A., as agent, and the other
financial institutions party thereto. On August 29, 2014, we
completed the $100 million delayed draw as part of the term loan A
facility. As part of the draw, we also completed cross currency
swaps, which convert our floating U.S. dollar denominated
obligation under the term loan A into a fixed Brazilian real
denominated obligation.
As a result of the refinancing, we recognized $18 million of
loss on refinancing activities on our condensed consolidated
statements of operations. This amount includes $13 million of
accelerated unamortized original issuance discount related to term
loan B and unamortized lender and non-lender fees related to the
entire credit facility. Also included in the loss on debt
redemption was $5 million of non-lender fees incurred in connection
with the Second Restatement Agreement. In addition, we recorded $2
million of lender fees which are included in the carrying amount of
the debt instruments. We also capitalized $5 million of non-lender
fees which are included in other assets, net on our condensed
consolidated balance sheet.
(8) Net earnings per common share is calculated under the
two-class method. See our Quarterly Report on Form 10-Q for further
details.
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
CONDENSED CONSOLIDATED BALANCE
SHEETS(1)
(Unaudited)
(In millions)
September 30, December
31, 2014 2013 Assets Current assets: Cash
and cash equivalents $ 420.7 $ 992.4 Trade receivables, net(2)
1,042.7 1,126.4 Other receivables 362.6 147.9 Inventories 765.7
688.4 Other current assets 321.0 462.6
Total
current assets 2,912.7 3,417.7 Property and
equipment, net 1,024.3 1,134.5 Goodwill 3,057.0 3,114.6 Intangible
assets, net 909.6 1,016.9 Other assets, net 450.9
450.5
Total assets $ 8,354.5 $
9,134.2 Liabilities and stockholders' equity Current
liabilities: Short-term borrowings $ 417.0 $ 81.6 Current portion
of long-term debt 1.3 201.5 Accounts payable 660.2 524.5 Settlement
agreement and related accrued interest(3) — 925.1 Other current
liabilities 941.8 968.1
Total current
liabilities 2,020.3 2,700.8 Long-term debt, less
current portion 4,197.7 4,116.4 Other liabilities 809.2
926.5
Total liabilities 7,027.2
7,743.7 Total parent company stockholders' equity 1,327.3
1,389.1 Noncontrolling interests — 1.4
Total
stockholders' equity 1,327.3
1,390.5 Total liabilities and stockholders' equity
$ 8,354.5 $ 9,134.2
CALCULATION OF NET DEBT
(1)
September 30, December 31,
2014 2013 Short-term borrowings $ 417.0
$ 81.6 Current portion of long-term debt 1.3 201.5 Settlement
agreement and related accrued interest(3) — 925.1 Long-term debt,
less current portion 4,197.7 4,116.4 Total debt
4,616.0 5,324.6 Less: cash and cash equivalents (420.7 )
(992.4 )
Net debt $ 4,195.3 $
4,332.2
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the
Securities and Exchange Commission.
(2) As of September 30, 2014, we had $87 million of borrowings
outstanding under our accounts receivable securitization programs,
and, accordingly, the trade receivables that serve as collateral
under these borrowings were reclassified from trade receivables,
net to other current assets.
(3) As previously disclosed in our Quarterly Report on
Form 10-Q for the three months ended March 31, 2014, on
February 3, 2014 we funded the cash consideration and issued
the shares reserved under the Settlement agreement.
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS(1)
(Unaudited)
(In millions)
Nine Months Ended September 30, 2014
2013 Revised(2) Net earnings available to common
stockholders - continuing operations $ 191.3 $ 90.1 Adjustments to
reconcile net earnings to net cash (used in) provided by operating
activities - continuing operations(3)
316.9 273.2 Changes in: Trade receivables, net (62.5 ) (34.7 )
Inventories (121.0 ) (107.6 ) Accounts payable 159.1 48.2
Settlement agreement and related accrued interest (4) (929.7 ) 36.2
Changes in all other operating assets and liabilities (35.8
) (35.4 )
Cash flow (used in) provided by operating
activities - continuing operations (481.7 )
270.0 Capital expenditures for property and equipment
(93.8 ) (79.6 ) Other investing activities 5.1 4.6
Cash flow used in investing activities - continuing
operations (88.7 ) (75.0 )
Net proceeds from short-term borrowings and long-term debt(5) 233.8
12.4 Repurchase of common stock (134.0 ) — Dividends paid on common
stock (83.9 ) (76.4 ) Acquisition of common stock for tax
withholding obligations under our 2005 contingent
stock plan
(2.9 ) (3.9 ) Payments of debt issuance costs (12.3 ) (7.7 )
Payments of debt extinguishment costs — (26.2 )
Cash flow provided by (used in) financing activities -
continuing operations 0.7 (101.8 )
Cash flow from discontinued operations —
7.8 Effect of foreign currency exchange
rates on cash and cash equivalents (2.0 )
(3.9 ) Cash and cash equivalents
beginning of period $ 992.4 $ 679.6
Net change in cash and cash equivalents (571.7 ) 97.1
Cash and cash equivalents end of period $
420.7 $ 776.7 Non-U.S. GAAP Free
Cash Flow: Cash flow from operating activities - continuing
operations(4) $ (481.7 ) $ 270.0 Capital expenditures for property
and equipment (93.8 ) (79.6 )
Free Cash
Flow(5)
$ (575.5 ) $ 190.4
Settlement agreement and related accrued interest (4) (929.7
) 36.2
Free Cash Flow excluding Settlement agreement and
related accrued interest $ 354.2 $
154.2 Additional Cash Flow Information: Interest
payments, net of amounts capitalized $ 660.6 $ 254.0 Income tax
payments $ 65.8 $ 77.2 SARs payments (less amounts included in
restructuring payments) $ 18.0 $ 42.8 Restructuring payments
(including associated costs) $ 75.8 $ 71.7
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the
Securities and Exchange Commission.
(2) In December 2013, we completed the sale of our rigid medical
packaging business. The financial results of the rigid medical
packaging business are reported as discontinued operations, net of
tax, and accordingly all previously reported financial information
has been revised.
(3) 2014 primarily consists of depreciation and amortization of
$242 million, profit sharing expense of $30 million, loss on debt
redemption and refinancing activities of $19 million and the
development grant matter of $14 million, partially offset by gain
on Settlement agreement of $(21) million. 2013 primarily consists
of depreciation and amortization of $263 million, loss on debt
redemption of $32 million and profit sharing expense of $30
million, partially offset by deferred taxes, net of $(49)
million.
(4) In February 2014, we used $930 million of cash to fund
the cash portion of the Settlement agreement and related accrued
interest. To fund the cash payment, we used $555 million of
cash and cash equivalents and utilized borrowings of
$260 million from our revolving credit facility and
$115 million from our accounts receivable securitization
programs.
(5) Free cash flow does not represent residual cash available
for discretionary expenditures, including mandatory debt servicing
requirements or non-discretionary expenditures that are not
deducted from this measure.
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
RECONCILIATION OF U.S. GAAP CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS TO
NON-U.S. GAAP ADJUSTED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND
NON-U.S. GAAP ADJUSTED
EBITDA((1))
(Unaudited)
(In millions, except per share
data)
Three Months Ended September 30,
2014 2013
U.S. GAAP
AsReported
SpecialItems(2)
Non-U.S.GAAPAdjusted
U.S.
GAAPAsReported
SpecialItems(2)
Non-U.S.GAAPAdjusted
Revised(3) Revised(3)
Net sales
$ 1,975.5 $ — $ 1,975.5
$ 1,912.0 $ — $ 1,912.0
Cost of sales 1,281.9 (1.8 ) 1,280.1
1,262.1 (0.7 ) 1,261.4
Gross profit
693.6 1.8 695.4 649.9 0.7
650.6 As a % of total net sales 35.1 % 35.2 % 34.0 % 34.0 %
Selling, general and administrative expenses 467.4 (20.9 ) 446.5
426.0 (7.6 ) 418.4 As a % of total net sales 23.7 % 22.6 % 22.3 %
21.9 % Amortization expense of intangible assets
acquired
30.4
— 30.4 29.1
— 29.1 Stock appreciation rights
expense 1.0 (1.0 )
— 8.7 (8.7 )
— Integration related
costs 1.4 (1.4 )
— 0.3 (0.3 )
— Restructuring and
other charges 11.4 (11.4 ) — 49.5
(49.5 ) —
Operating profit 182.0
36.5 218.5 136.3 66.8 203.1 As a
% of total net sales 9.2 % 11.1 % 7.1 % 10.6 % Interest expense
(69.7 ) — (69.7 ) (88.9 ) — (88.9 ) Impairments of equity method
investment 0.2 (0.2 ) — (2.1 ) 2.1 — Foreign currency exchange
(losses) gains related to
Venezuelan subsidiaries
(4.1 ) 4.1 — 0.7 (0.7 ) — Gain from Claims Settlement — — — — — —
Loss on debt redemption and refinancing activities (17.7 ) 17.7 — —
— — Other income (expense), net 4.3 (0.1 ) 4.2
0.3 0.4 0.7
Earnings from continuing
operations before
income tax provision
95.0 58.0 153.0 46.3 68.6
114.9 Income tax provision 35.7 6.8
42.5 11.2 14.2 25.4 Effective income tax rate
37.6 % 27.8 % 24.2 % 22.1 %
Net earnings from continuing
operations 59.3 51.2 110.5 35.1
54.4 89.5 Net earnings from discontinued operations
— — — 2.5 (2.5 ) —
Net
earnings available to common stockholders $ 59.3
$ 51.2 $ 110.5 $ 37.6
$ 51.9 $ 89.5 Net earnings per
common share: Diluted: Continuing operations $ 0.28 $
0.24 $ 0.52 $ 0.17 $ 0.25 $ 0.42 Discontinued operations —
— — 0.01 (0.01 ) —
Net
earnings per common share -
diluted
$ 0.28 $ 0.24 $ 0.52
$ 0.18 $ 0.24 $ 0.42
Weighted average number of common shares
outstanding:
Diluted 213.9 213.9
213.9 213.7 213.7
213.7 Non-U.S. GAAP Adjusted EBITDA: Non-U.S. GAAP
Adjusted Operating Profit $ 218.5 $
203.1 Other income (expense), net 4.2 0.7 Depreciation and
amortization(4) 77.3 72.7 Write down of non-strategic assets,
included in
depreciation and amortization
(0.4 ) —
Non-U.S. GAAP Adjusted EBITDA
$ 299.6 $ 276.5 As a % of total net
sales 15.2 % 14.5 %
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the
Securities and Exchange Commission.
(2) Special items consist of certain one-time costs or
charges/credits that are included in our U.S. GAAP reported
results. These special items include restructuring and other
associated costs related to our previously announced Earnings
Quality Improvement Program (“EQIP”) and the Integration and
Optimization Program (“IOP”) restructuring programs, foreign
currency exchange losses related to Venezuelan subsidiaries and
stock appreciation rights (“SARs”) expense and, in 2014, the
development grant matter and losses recorded on debt redemption and
refinancing activities.
(3) In December 2013, we completed the sale of our rigid medical
packaging business. The financial results of the rigid medical
packaging business is reported as discontinued operations, net of
tax, and accordingly all previously reported financial information
has been revised.
(4) Depreciation and amortization includes:
Three
Months Ended September 30, 2014
2013 Depreciation of property, plant and equipment $ 36.6 $
38.1 Amortization of intangible assets acquired
30.4
29.1 Amortization of deferred share-based compensation 10.3
5.5
Total
$
77.3
$
72.7
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
RECONCILIATION OF U.S. GAAP CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS TO
NON-U.S. GAAP ADJUSTED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND NON-U.S. GAAP
ADJUSTED EBITDA(1)
(Unaudited)
(In millions, except per share
data
Nine Months Ended
September 30, 2014 2013
U.S. GAAP
AsReported
SpecialItems(2)
Non-U.S.GAAPAdjusted
U.S. GAAP
AsReported
SpecialItems(2)
Non-U.S.GAAPAdjusted
Net sales $ 5,776.8 $ —
$ 5,776.8 $ 5,678.3
$ — $ 5,678.3 Cost of sales
3,762.3 (8.1 ) 3,754.2 3,757.1
(5.7 ) 3,751.4
Gross profit 2,014.5 8.1
2,022.6 1,921.2 5.7 1,926.9 As a % of
total net sales 34.9 % 35.0 % 33.8 % 33.9 % Selling, general and
administrative expenses 1,374.5 (29.8 ) 1,344.7 1,310.6 (19.2 )
1,291.4 As a % of total net sales 23.8 % 23.3 % 23.1 % 22.7 %
Amortization expense of intangible assets acquired 92.8 — 92.8 92.4
— 92.4 Stock appreciation rights expense 3.2 (3.2 ) — 26.8 (26.8 )
— Integration related costs 3.3 (3.3 ) — 0.7 (0.7 ) — Restructuring
and other charges 31.6 (31.6 ) — 61.2
(61.2 ) —
Operating profit 509.1
76.0 585.1 429.5 113.6 543.1 As
a % of total net sales 8.8 % 10.1 % 7.6 % 9.6 % Interest expense
(222.1 ) — (222.1 ) (269.4 ) — (269.4 ) Impairments of equity
method investment (5.7 ) 5.7 — (2.1 ) 2.1 — Foreign currency
exchange (losses) gains related to
Venezuelan subsidiaries
(18.9 ) 18.9 — (12.9 ) 12.9 — Gain from Claims Settlement 21.1
(21.1 ) — — — — Loss on debt redemption and refinancing activities
(18.5 ) 18.5 — (32.4 ) 32.4 — Other income (expense), net
5.8 3.6 9.4 (2.7 ) 0.7 (2.0 )
Earnings from continuing operations before income
tax provision
270.8 101.6 372.4 110.0 161.7
271.7 Income tax provision 79.5 20.4
99.9 19.9 38.5 58.4 Effective income tax rate
29.4 % 26.8 % 18.1 % 21.5 %
Net earnings from continuing
operations 191.3 81.2 272.5 90.1
123.2 213.3 Net earnings from discontinued operations
— — — 6.5 (6.5 ) —
Net
earnings available to common stockholders $ 191.3
$ 81.2 $ 272.5 $ 96.6
$ 116.7 $ 213.3 Net earnings per
common share: Diluted: Continuing operations $ 0.88 $
0.38 $ 1.26 $ 0.42 $ 0.58 $ 1.00 Discontinued operations —
— — 0.03 (0.03 ) —
Net
earnings per common share - diluted $ 0.88
$ 0.38 $ 1.26 $ 0.45
$ 0.55 $ 1.00 Weighted
average number of common shares
outstanding:
Diluted 215.7 215.7
215.7 213.4 213.4
213.4 Non-U.S. GAAP Adjusted EBITDA: Non-U.S. GAAP
Adjusted Operating Profit $ 585.1 $
543.1 Other income (expense), net 9.4 (2.0 ) Depreciation
and amortization(4) 241.7 234.0 Write down of non-strategic assets,
included in
depreciation and amortization
(0.2 ) (5.0 )
Non-U.S. GAAP Adjusted EBITDA
$ 836.0 $ 770.1 As a % of total net
sales 14.5 % 13.6 %
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the Securities
and Exchange Commission.
(2) Special items consist of certain one-time costs or
charges/credits that are included in our U.S. GAAP reported
results. These special items include restructuring and other
associated costs related to our previously announced EQIP and IOP
restructuring programs, foreign currency exchange losses related to
Venezuelan subsidiaries, losses recorded on debt redemption and
refinancing activities and stock appreciation rights (“SARs”)
expense and, in 2014, the gain from Claims Settlement and the
development grant matter.
(3) In December 2013, we completed the sale of our rigid medical
packaging business. The financial results of the rigid medical
packaging business is reported as discontinued operations, net of
tax, and, accordingly all previously reported financial information
has been revised.
(4) Depreciation and amortization includes:
Nine Months
Ended September 30, 2014
2013 Depreciation of property, plant and equipment $ 112.2 $
121.2 Amortization of intangible assets acquired 92.8 92.4
Amortization of deferred share-based compensation 36.7
20.4
Total $ 241.7 $
234.0
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
SEGMENT INFORMATION(1)
(Unaudited)
Three Months Ended Nine Months
Ended September 30, %
September 30, % 2014 2013
Change 2014 2013 Change
Revised(2) Revised(2)
Net Sales: Food Care $
983.4 $ 951.0 3.4 % $ 2,849.9 $ 2,801.1 1.7 % As a % of Total
Company net sales 49.8 % 49.7 % 49.3 % 49.3 % Diversey Care 550.8
532.0 3.5 % 1,637.2 1,614.9 1.4 % As a % of Total Company net sales
27.9 % 27.8 % 28.3 % 28.4 % Product Care 420.7 403.1 4.4 % 1,223.2
1,185.1 3.2 % As a % of Total Company net sales 21.3 %
21.1 % 21.2 % 20.9 %
Total Reportable Segments Net Sales 1,954.9
1,886.1 3.6 %
5,710.3 5,601.1
1.9 % Other 20.6 25.9 (20.4 ) %
66.5 77.2 (13.8 ) %
Total Company Net Sales
$ 1,975.5 $ 1,912.0 3.4 %
$ 5,776.8 $ 5,678.3 1.7 %
Three Months Ended Nine
Months Ended September 30,
% September 30, % 2014
2013 Change 2014
2013 Change Revised(2) Revised(2)
Adjusted
EBITDA: Food Care $ 178.4 $ 160.6 11.1 % $ 497.3 $ 454.5 9.4 %
Adjusted EBITDA Margin 18.1 % 16.9 % 17.4 % 16.2 % Diversey Care
69.9 60.7 15.2 % 186.7 176.6 5.7 % Adjusted EBITDA Margin 12.7 %
11.4 % 11.4 % 10.9 % Product Care 74.4 69.4 7.2 % 215.4 193.3 11.4
% Adjusted EBITDA Margin 17.7 % 17.2 %
17.6 % 16.3 %
Total Reportable
Segments Adjusted
EBITDA
322.7 290.7 11.0 %
899.4 824.4
9.1 % Other (23.1 ) (14.2 ) 62.7 %
(63.4 ) (54.3 ) 16.7 %
Non-U.S. GAAP Total
Company
Adjusted EBITDA
$ 299.6 $ 276.5 8.4 %
$ 836.0 $ 770.1 8.6 %
Adjusted EBITDA Margin 15.2 % 14.5 % 14.5 % 13.6 %
(1) As previously announced, effective as of January 1,
2014, the Company changed its segment reporting structure in order
to reflect the way management now makes operating decisions and
manages the growth and profitability of the business. See our
Current Report on Form 8-K filed with the SEC on
April 16, 2014 for further details. The supplementary
information included in this press release for 2014 is preliminary
and subject to change prior to the filing of our upcoming Quarterly
Report on Form 10-Q with the Securities and Exchange
Commission.
(2) In December 2013, we completed the sale of our rigid medical
packaging business. The financial results of the rigid medical
packaging business is reported as discontinued operations, net of
tax, and accordingly all previously reported financial information
has been revised.
SEALED AIR CORPORATION
SEGMENT INFORMATION – CONTINUED
SUPPLEMENTARY
INFORMATION(1)
RECONCILIATION OF NON-U.S. GAAP TOTAL
COMPANY ADJUSTED EBITDA TO
U.S. GAAP NET EARNINGS FROM CONTINUING
OPERATIONS
(Unaudited)
Three Months Ended Nine
Months Ended September 30, September 30,
2014 2013 2014
2013 Revised(2) Revised(2)
Non-U.S. GAAP Total Company
Adjusted EBITDA $ 299.6 $ 276.5
$ 836.0 $ 770.1 Depreciation and
amortization (3) (77.3 ) (72.7 ) (241.7 ) (234.0 ) Special
items(4): Write down of non-strategic assets included in
depreciation
and amortization
0.4 — 0.2 5.0 Restructuring and other charges(5) (11.4 ) (49.5 )
(31.6 ) (61.2 ) Other restructuring associated costs included in
cost of
sales and selling, general and
administrative expenses
(8.0 ) (8.3 ) (23.4 ) (24.9 ) Development grant matter included in
selling, general and administrative expenses (14.0 ) — (14.0 ) —
Relocation costs included in selling, general and administrative
expenses (0.5 ) — (0.5 ) — SARs (1.0 ) (8.7 ) (3.2 ) (26.8 )
Integration related costs (1.4 ) (0.3 ) (3.3 ) (0.7 ) Impairments
of equity method investment 0.2 (2.1 ) (5.7 ) (2.1 ) Foreign
currency exchange (losses) gains related to
Venezuelan subsidiaries
(4.1 ) 0.7 (18.9 ) (12.9 ) Loss on debt redemption and refinancing
activities (17.7 ) — (18.5 ) (32.4 ) Gain from Claims Settlement in
2014 and related costs (0.1 ) (0.3 ) 20.5 (0.6 ) Non-operating
charge for contingent guarantee included in
other income (expense), net
(2.5 ) — (2.5 ) — Other income (expense), net 2.5 (0.1 ) (0.5 )
(0.1 ) Interest expense (69.7 ) (88.9 ) (222.1 ) (269.4 ) Income
tax provision 35.7 11.2 79.5 19.9
U.S. GAAP net earnings from continuing operations $
59.3 $ 35.1 $ 191.3 $
90.1
Notes:
(1) The supplementary information included in this press release
for 2014 is preliminary and subject to change prior to the filing
of our upcoming Quarterly Report on Form 10-Q with the
Securities and Exchange Commission.
(2) In December 2013, we sold our rigid medical packaging
business. The financial results of the rigid medical packaging
business are reported as discontinued operations, net of tax, and
accordingly all previously reported financial information has been
revised.
(3) Depreciation and amortization by segment is as follows:
Three Months Ended Nine
Months Ended September 30, September 30,
2014 2013 2014
2013 Revised(2) Revised(2) Food Care $ 30.6 $
29.9 $ 92.1 $ 89.3 Diversey Care 31.9 30.9 98.9 99.0 Product Care
9.8 9.4 30.7 28.8
Total reportable
segments 72.3 70.2 221.7 217.1
Other 5.0 2.5 20.0 16.9
Total
Company depreciation and amortization $ 77.3
$ 72.7 $ 241.7 $ 234.0
(4) Includes items we consider unusual or special items. See
Note 2 of “Reconciliation of U.S. GAAP Condensed Consolidated
Statements of Operations to Non-U.S. GAAP Adjusted Condensed
Consolidated Statements of Operations and Non-U.S. GAAP Adjusted
EBITDA,” for further information.
(5) Restructuring and other charges by segment is as
follows:
Three Months Ended Nine Months Ended
September 30, September 30, 2014
2013 2014
2013 Revised(2) Revised(2) Food Care $ 1.8 $ 16.4 $ 12.9 $
19.9 Diversey Care 8.2 21.4 12.0 26.3 Product Care 1.3
10.4 6.3 13.6
Total reportable segments
11.3 48.2 31.2 59.8 Other 0.1
1.3 0.4 1.4
Total Company restructuring and
other charges $ 11.4 $ 49.5
$ 31.6 $ 61.2
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
COMPONENTS OF CHANGE IN NET SALES BY
SEGMENT(1)
(Unaudited)
(In millions)
Three Months Ended September 30, 2014 Food
Care Diversey Care
Product Care Other Total
Company
Volume - Units $ (1.4 ) (0.1 ) % $ 19.7 3.7 %
$ (2.4 ) (0.6 ) % $ (7.1 ) (27.4 ) % $
8.8 0.5 % Product price/mix (2) 38.3 4.0 1.1 0.2 18.0 4.5
1.7 6.6 59.1 3.1 Foreign currency translation (4.5 )
(0.5 ) (2.0 ) (0.4 ) 2.0 0.5 0.1
0.4 (4.4 ) (0.2 )
Total change (U.S.
GAAP) $ 32.4 3.4 % $
18.8 3.5 % $ 17.6
4.4 % $ (5.3 )
(20.4 ) % $ 63.5
3.4 % Foreign currency translation 4.5
0.5 % 2.0 0.4 % (2.0 ) (0.5 ) %
(0.1 ) (0.4 ) % 4.4 0.2 %
Total constant
dollar change
(Non-U.S. GAAP)(3)
$ 36.9 3.9 % $
20.8 3.9 % $ 15.6
3.9 % $ (5.4 )
(20.8 ) % $ 67.9
3.6 % Nine Months Ended September
30, 2014 Food Care Diversey Care
Product Care Other
Total
Company
Volume - Units $ (11.3 ) (0.4 ) % $ 14.2 0.9 %
$ 0.2 — % $ (14.0 ) (18.1 ) % $ (10.9 )
(0.2 ) % Product price/mix (2) 118.6 4.2 28.0 1.7 38.6 3.3
2.7 3.5 187.9 3.3 Foreign currency translation (58.5 )
(2.1 ) (19.9 ) (1.2 ) (0.7 )
(0.1 ) 0.6 0.8 (78.5 ) (1.4 )
Total
change (U.S. GAAP) $ 48.8 1.7
% $ 22.3 1.4 % $
38.1 3.2 % $ (10.7
) (13.8 ) % $ 98.5
1.7 % Foreign currency translation 58.5
2.1 % 19.9 1.2 % 0.7 0.1 %
(0.6 ) (0.8 ) % 78.5 1.4 %
Total
constant dollar change
(Non-U.S. GAAP)(3)
$ 107.3 3.8 % $
42.2 2.6 % $ 38.8
3.3 % $ (11.3 )
(14.6 ) % $ 177.0
3.1 %
(1) The results above are presented on a continuing operations
basis, excluding our rigid medical packaging business, which we
sold in December 2013. The supplementary information included in
this press release for 2014 is preliminary and subject to change
prior to the filing of our upcoming Quarterly Report on
Form 10-Q with the Securities and Exchange Commission.
(2) Our product price/mix reported above includes the net impact
of our pricing actions and rebates as well as the period-to-period
change in the mix of products sold. Also included in our reported
product price/mix is the net effect of some of our customers
purchasing our products in non-U.S. dollar or euro denominated
countries at selling prices denominated in U.S. dollars or
euros. This primarily arises when we export products from the U.S.
and euro-zone countries.
(3) Changes in these items excluding the impact of foreign
currency translation are non-U.S. GAAP financial measures. Since we
are a U.S. domiciled company, we translate our
foreign-currency-denominated financial results into
U.S. dollars. Due to changes in the value of foreign
currencies relative to the U.S. dollar, translating our
financial results from foreign currencies to U.S. dollars may
result in a favorable or unfavorable impact. It is important that
we take into account the effects of foreign currency translation
when we view our results and plan our strategies. Nonetheless, we
cannot control changes in foreign currency exchange rates.
Consequently, when our management looks at our financial results to
measure the core performance of our business, we exclude the impact
of foreign currency translation by translating our current period
results at prior period foreign currency exchange rates. We also
may exclude the impact of foreign currency translation when making
incentive compensation determinations. As a result, our management
believes that these presentations are useful internally and may be
useful to our investors.
SEALED AIR CORPORATION
SUPPLEMENTARY INFORMATION
COMPONENTS OF CHANGE IN NET SALES BY
REGION(1)
Unaudited
(In millions)
Three Months Ended September 30, 2014
NorthAmerica
Europe
LatinAmerica
AMAT(2) JANZ(3)
Total Change in Net Sales Volume - Units $ 6.6 $ (1.8
) $ (9.3 ) $ 10.1 $ 3.2 $ 8.8 % change 0.9 % (0.3 ) % (4.4 ) % 4.7
% 2.5 % 0.5 % Product price/mix 17.0 7.5 25.9 5.7 3.0 59.1 % change
2.3 % 1.3 % 12.4 % 2.6 % 2.2 % 3.1 % Foreign currency translation
(2.4 ) 11.7 (15.8 ) (2.1 ) 4.2 (4.4 ) % change (0.3 ) %
2.0 % (7.6 ) % (1.0 ) % 3.2 %
(0.2 ) %
Total change (U.S. GAAP) $ 21.2
$ 17.4 $ 0.8 $ 13.7
$ 10.4 $ 63.5 % change 2.9 % 3.0 % 0.4
% 6.3 % 7.9 % 3.4 % Foreign currency translation $ 2.4 $
(11.7 ) $ 15.8 $ 2.1 $ (4.2 ) $ 4.4
Total constant dollar
change
(Non-U.S. GAAP)
$ 23.6 $ 5.7 $ 16.6
$ 15.8 $ 6.2 $ 67.9
Constant dollar % change 3.2 % 1.0 % 8.0 % 7.3 % 4.7 % 3.6 %
Nine Months Ended September 30, 2014
NorthAmerica
Europe
LatinAmerica
AMAT(2) JANZ(3)
Total Change in Net Sales Volume - Units $ (10.0 ) $
(8.5 ) $ (20.7 ) $ 29.3 $ (1.0 ) $ (10.9 ) % change (0.4 ) % (0.5 )
% (3.3 ) % 4.6 % (0.2 ) % (0.2 ) % Product price/mix 78.0 11.6 72.7
14.8 10.8 187.9 % change 3.5 % 0.7 % 11.7 % 2.3 % 2.6 % 3.3 %
Foreign currency translation (13.4 ) 56.9 (76.5 ) (26.9 ) (18.6 )
(78.5 ) % change (0.6 ) % 3.2 % (12.3 ) %
(4.2 ) % (4.5 ) % (1.4 ) %
Total change
(U.S. GAAP) $ 54.6 $ 60.0 $
(24.5 ) $ 17.2 $ (8.8
) $ 98.5 % change 2.5 % 3.4 % (3.9 ) % 2.7 %
(2.1 ) % 1.7 % Foreign currency translation 13.4
(56.9 ) 76.5 26.9 18.6 78.5
Total constant dollar change
(Non-U.S. GAAP)
$ 68.0 $ 3.1 $ 52.0
$ 44.1 $ 9.8 $ 177.0
Constant dollar % change 3.1 % 0.2 % 8.4 % 6.9 % 2.4 % 3.1 %
(1) The results above are presented on a continuing operations
basis, excluding our rigid medical packaging business, which we
sold in December 2013. The supplementary information included in
this press release for 2014 is preliminary and subject to change
prior to the filing of our upcoming Quarterly Report on
Form 10-Q with the Securities and Exchange Commission.
(2) AMAT consists of Asia, Middle East, Africa and Turkey.
(3) JANZ consists of Japan, Australia and New Zealand.
Sealed Air CorporationInvestor:Lori Chaitman,
201-703-4161orMedia Contact:Ken Aurichio, 201-703-4164
Sealed Air (NYSE:SEE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sealed Air (NYSE:SEE)
Historical Stock Chart
From Apr 2023 to Apr 2024